Decreases Glucagon: Reduces production of glucagon, a hormone that raises blood sugar, preventing unnecessary glucose release from the liver
consults for and advises AstraZeneca and Avant Sant, consults for and has received grants from Akero, Bristol Myers Squibb, Eli Lilly, Intercept, Madrigal and Novo Nordisk, consults for and owns stock in Rivus, consults for 89bio, AGED Diagnostics, Albireo, Alnylam, Altimmune, Boehringer Ingelheim, Echosens, Genentech, Gilead, GlaxoSmithKline, HistoIndex, Mallinckrodt, Merck, NGM Bio, Novartis, PathAI, Pfizer, Poxel, Regeneron, Salix, Siemens, Surrozen, Takeda, Terns and Zydus, owns stock in Durect, Exalenz, Genfit, Indalo, Inversago and Tiziana, and has received royalties from Elsevier and Wolters Kluwer
Kozlovskaya MM, et al
Cell 175 , 665678.e23 (2018)